» Articles » PMID: 27548525

A Hidden Residential Cell in the Lung

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2016 Aug 23
PMID 27548525
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Eosinophils are classically known as proinflammatory cells, as they are equipped with a variety of preformed cytotoxic mediators and have been shown to definitively contribute to asthma. The connection between eosinophils and asthma development has led to a new class of asthma therapeutics based on blocking eosinophils with humanized antibodies that neutralize IL-5, a potent eosinophil growth, activation, and survival factor. Yet, recent studies have led to an increasing appreciation that eosinophils have a variety of homeostatic functions, including immunomodulation. In this issue of the JCI, Mesnil et al. identify a notable population of lung-resident eosinophils and demonstrate that, compared with traditional eosinophils, these cells have distinct characteristics, including nuclear structure, surface markers, IL-5 independence, and immunoregulatory function that is capable of polarizing adaptive immune responses, at least in vitro. Thus, these results reinforce a key homeostatic role for this enigmatic cell population, particularly in residing and regulating immunity in the lung.

Citing Articles

Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution.

De Volder J, Bontinck A, Haelterman V, Boon L, Joos G, Brusselle G Respir Res. 2025; 26(1):43.

PMID: 39875874 PMC: 11773929. DOI: 10.1186/s12931-024-03082-9.


Increased mucosal eosinophils in colonic diverticulosis and diverticular disease.

Cameron R, Walker M, Jones M, Eslick G, Keely S, Pockney P J Gastroenterol Hepatol. 2023; 38(8):1355-1364.

PMID: 37415341 PMC: 10946982. DOI: 10.1111/jgh.16278.


Subsets of Eosinophils in Asthma, a Challenge for Precise Treatment.

Novosad J, Krcmova I, Soucek O, Drahosova M, Sedlak V, Kulirova M Int J Mol Sci. 2023; 24(6).

PMID: 36982789 PMC: 10052006. DOI: 10.3390/ijms24065716.


PI3Kδ inhibition prevents IL33, ILC2s and inflammatory eosinophils in persistent airway inflammation.

Uddin S, Amour A, Lewis D, Edwards C, Williamson M, Hall S BMC Immunol. 2021; 22(1):78.

PMID: 34920698 PMC: 8684271. DOI: 10.1186/s12865-021-00461-5.


Pulmonary Eosinophils at the Center of the Allergic Space-Time Continuum.

Schetters S, Schuijs M Front Immunol. 2021; 12:772004.

PMID: 34868033 PMC: 8634472. DOI: 10.3389/fimmu.2021.772004.


References
1.
Qiu Y, Nguyen K, Odegaard J, Cui X, Tian X, Locksley R . Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell. 2014; 157(6):1292-1308. PMC: 4129510. DOI: 10.1016/j.cell.2014.03.066. View

2.
Rothenberg M, Hogan S . The eosinophil. Annu Rev Immunol. 2006; 24:147-74. DOI: 10.1146/annurev.immunol.24.021605.090720. View

3.
Chu V, Beller A, Rausch S, Strandmark J, Zanker M, Arbach O . Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. Immunity. 2014; 40(4):582-93. DOI: 10.1016/j.immuni.2014.02.014. View

4.
Fulkerson P, Rothenberg M . Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov. 2013; 12(2):117-29. PMC: 3822762. DOI: 10.1038/nrd3838. View

5.
Rothenberg M . Humanized Anti-IL-5 Antibody Therapy. Cell. 2016; 165(3):509. DOI: 10.1016/j.cell.2016.04.020. View